Sarcopenia, Sarcopenic obesity and mortality in older adults: results from the National Health and Nutrition Examination Survey III

Citation metadata

Authors: J.A. Batsis, T.A. Mackenzie, L.K. Barre, F. Lopez-Jimenez and S.J. Bartels
Date: Sept. 2014
From: European Journal of Clinical Nutrition(Vol. 68, Issue 9)
Publisher: Nature Publishing Group
Document Type: Report
Length: 5,225 words

Main content

Abstract :

BACKGROUND: Sarcopenia is defined as the loss of skeletal muscle mass and quality, which accelerates with aging and is associated with functional decline. Rising obesity prevalence has led to a high- risk group with both disorders. We assessed mortality risk associated with sarcopenia and sarcopenic obesity in elders. METHODS: A subsample of 4652 subjects [greater than or equal to] 60 years of age was identified from the National Health and Nutrition Examination Survey III (1988-1994), a cross-sectional survey of non-institutionalized adults. National Death Index data were linked to this data set. Sarcopenia was defined using a bioelectrical impedance formula validated using magnetic resonance imaging-measured skeletal mass by Janssen et al. Cutoffs for total skeletal muscle mass adjusted for height (2) were sex-specific (men: [less than or equal to] 5.75 kg/[m.sup.2]; females [less than or equal to] 10.75 kg/[m.sup.2]). Obesity was based on % body fat (males: [greater than or equal to] 27%, females: [greater than or equal to] 38%). Modeling assessed mortality adjusting for age, sex, ethnicity (model 1), comorbidities (hypertension, diabetes, congestive heart failure, osteoporosis, cancer, coronary artery disease and arthritis), smoking, physical activity, self-reported health (model 2) and mobility limitations (model 3). RESULTS: Mean age was 70.6 [+ or -] 0.2 years and 57.2% were female. Median follow-up was 14.3 years (interquartile range: 12.5-16.1). Overall prevalence of sarcopenia was 35.4% in women and 75.5% in men, which increased with age. Prevalence of obesity was 60.8% in women and 54.4% in men. Sarcopenic obesity prevalence was 18.1% in women and 42.9% in men. There were 2782 (61.7%) deaths, of which 39.0% were cardiovascular. Women with sarcopenia and sarcopenic obesity had a higher mortality risk than those without sarcopenia or obesity after adjustment (model 2, hazard ratio (HR): 1.35 (1.05-1.74) and 1.29 (1.03-1.60)). After adjusting for mobility limitations (model 3), sarcopenia alone (HR: 1.32 ((1.04- 1.69) but not sarcopenia with obesity (HR: 1.25 (0.99-1.58)) was associated with mortality. For men, the risk of death with sarcopenia and sarcopenic obesity was nonsignificant in both model-2 (HR: 0.98 (0.77-1.25), and HR: 0.99 (0.79-1.23)) and model 3 (HR: 0.98 (0.77-1.24) and HR: 0.98 (0.79-1.22)). CONCLUSIONS: Older women with sarcopenia have an increased all-cause mortality risk independent of obesity. European Journal of Clinical Nutrition (2014) 68, 1001-1007; doi: 10.1038/ejcn.2014.117; published online 25 June 2014

Source Citation

Source Citation
Batsis, J.A., et al. "Sarcopenia, Sarcopenic obesity and mortality in older adults: results from the National Health and Nutrition Examination Survey III." European Journal of Clinical Nutrition, vol. 68, no. 9, 2014, p. 1001+. Accessed 22 Oct. 2020.

Gale Document Number: GALE|A381409272